Achilles’ heel of Ebola virus identified in new study
27 May 2015 | By Victoria White
An international team of scientists has identified the molecular “lock” that the deadly Ebola virus must pick to gain entry to cells...
List view / Grid view
News
An interview with Ben Busby, National Center for Biotechnology Information (NCBI)
26 May 2015 | By Oxford Global Conferences
In the run up to the Next Generation Sequencing USA Congress & co-located Single Cell Genomics and Transcriptomics USA Congress, Oxford Global Conferences interviewed Ben Busby, Genomics Outreach Coordinator, NCBI...
TSRI chemists devise inexpensive method for synthesising amines
26 May 2015 | By Victoria White
Chemists at The Scripps Research Institute (TSRI) have discovered a broad and strikingly inexpensive method for synthesising amines...
Eisai to promote clinical trial data disclosure for the advancement of science and medicine
26 May 2015 | By Victoria White
In order to promote transparency in clinical trial data disclosure, Eisai is making its clinical trial data available to researchers via an external website...
Anti-stroke drug Vinpocetine could be effective as a treatment for middle-ear infections
22 May 2015 | By Victoria White
Vinpocetine is an effective treatment for middle-ear infections, showing the ability to improve bacterial clearance and reduce hearing loss...
Janssen and Achillion enter into worldwide collaboration to combat Hepatitis C
22 May 2015 | By Victoria White
Achillion and Janssen have entered into a worldwide license and collaboration arrangement to develop and commercialise one or more of Achillion's HCV assets...
Eureka Therapeutics and Boehringer Ingelheim enter into antibody research agreement
22 May 2015 | By Victoria White
Eureka Therapeutics and Boehringer Ingelheim have entered into a research agreement for the discovery of novel therapeutic antibodies in oncology...
Scientists unveil ‘Rosetta Stone’ of prostate cancer
21 May 2015 | By Victoria White
Almost 90% of men with advanced prostate cancer carry genetic mutations in their tumours that could be targeted by either existing or new cancer drugs...
Re-engineered spectinomycin shows potential for treatment of drug-resistant bacteria
21 May 2015 | By Victoria White
Researchers have developed a second-generation of spectinomycin that shows early effectiveness against common bacterial infections...
Alnylam files Clinical Trial Application for ALN-AAT for the treatment of Alpha-1 Liver Disease
21 May 2015 | By Victoria White
Alnylam has filed a Clinical Trial Application to initiate a Phase 1/2 clinical trial with ALN-AAT for the treatment of alpha-1 liver disease...
Orphan Drug Designation granted in the EU for ISTH0036 to treat advanced-stage glaucoma
21 May 2015 | By Victoria White
The EMA has granted orphan drug designation for ISTH0036, a locked nucleic acid-modified antisense oligonucleotide, to treat advanced-stage glaucoma...
First cancer-promoting oncogenes discovered in choroid plexus carcinoma
21 May 2015 | By Victoria White
Researchers have identified three genes that play a pivotal role in choroid plexus carcinoma, a discovery that could lead to more effective treatment...
Zealand starts clinical development of a multiple-dose version of ZP4207
20 May 2015 | By Victoria White
Zealand has advanced a multiple-dose version of ZP4207 into clinical development for the treatment of mild to moderate hypoglycaemia in diabetes patients...
Ipsen signs agreement to acquire Octreopharm Sciences
20 May 2015 | By Victoria White
Ipsen signed an agreement to acquire OctreoPharm Sciences, a life sciences company focusing on the development of innovative radioactive labelled compounds...
Mucosis to present data on intranasal RSV vaccine SynGEM at MVADS 2015
19 May 2015 | By Victoria White
Dr Leenhouts is set to discuss the progress with Mucosis' intranasal respiratory syncytial virus (RSV) vaccine candidate, SynGEM, at MVADS 2015...